Aro raises $41M; Candel’s layoffs; Lilly to expand its accelerator to San Diego

Plus, news about Erasca, Exonate, AnaptysBio, Flagship and AstraZeneca:

Aro Biotherapeutics raises $41.5M: The Philadelphia genetic medicines startup said Tuesday that Cowen Healthcare Investments led the Series B. Existing investors also took part, including JNJ Innovation, Northpond Ventures, HealthCap and BVF Partners. The financing, however, came…
Click here to view original post